Charles River Laboratories (CRL) Expands Virtual Control Group Use In Toxicology Studies

What happened: Charles River Laboratories (NYSE:CRL) agreed to deploy its Virtual Control Group database for Ipsen to support toxicology studies and reduce animal use. Why it matters: The article frames these deals as supporting Charles River's shift toward higher value, data-led services, positioning it alongside peers in complex regulatory science. It notes investors still have limited visibility on how large these programs might become. Key numbers: The article cites a $316 fair value for Charles River Laboratories International. Market: +0.6% today ($376.10), +85.8% YTD, 0.9x vol — as of 10:00 UTC

Charles River Laboratories (NYSE:CRL) agreed to deploy its Virtual Control Group database for Ipsen to support toxicology studies and reduce animal use.

The article frames these deals as supporting Charles River's shift toward higher value, data-led services, positioning it alongside peers in complex regulatory science. It notes investors still have limited visibility on how large these programs might become. Key numbers: The article cites a $316 fair value for Charles River Laboratories International. Market: +0.6% today ($376.10), +85.8% YTD, 0.9x vol — as of 10:00 UTC